FDA staff report says data shows Pfizer's Covid treatment Paxlovid is effective in high-risk adults
March 14, 2023 at 15:04 PM EDT
FDA staff said Pfizer's clinical trial results on its Covid antiviral pill Paxlovid support its use in adults at high risk of progressing to severe disease.
